Economic Justification for Integrated Care Models
In 2011 the Veterans’ Administration (VA) published a study in Stroke, “An Economic Analysis of Robot-Assisted Therapy for Long-Term Upper-Limb Impairment after Stroke. ” This was a large multi-site randomized controlled clinical trial using InMotion upper extremity robots to deliver intensive sensorimotor therapy to chronic stroke patients.
- The conclusion offers that the cost of delivering InMotion robot therapy was recuperated by lower health care use costs.
“Advances in robotics and an increased understanding of the latent neurologic potential for stroke recovery led to our initiation of this multicenter, randomized, controlled trial, called the Veterans Affairs (VA) Robotic-Assisted Upper-Limb Neurorehabilitation in Stroke Patients study, to determine whether a rehabilitation protocol using the MIT–Manus robotic system (Interactive Motion Technologies), as compared with a program based on conventional rehabilitative techniques or usual care, could improve functioning and quality of life of stroke survivors with long-term upper-limb deficits.”
The cost-efficiency of InMotion Robots can become the foundation for an evidence-based rationale supporting investment in a neuro-recovery program spanning the
Total cost over 36 weeks
Therapy + all other healthcare utilization
- Robot $17,831 (other healthcare $12,679)
- ICT $19,746 (other healthcare $12,364)
- Usual Care $19,098 (other healthcare $19,098)
- In fact, each patient in the robot treated group consumed $6,419 less “other” healthcare services during the 36 weeks when healthcare expenses were tracked.
- This is the first clinical trial that demonstrates a rehabilitation intervention (robot-assisted therapy) can reduce health care resource utilization, improve patient quality of life and enable modest improvements in functioning among patients with chronic upper-extremity disability related to stroke.
- The cost-efficiency of InMotion Robots can become the foundation for an evidence-based rationale supporting investment in a neuro-recovery program spanning the recovery continuum.
“The added cost of delivering robot or intensive comparison therapy was recuperated by lower healthcare use costs compared with those in the usual care group”